Early strategy of scepter XC balloon angioplasty and simultaneous Nimodipine infusion for vasospasm following ruptured aneurysm

Background Cerebral vasospasm still results in high morbidity and mortality rates in patients after aneurysmal subarachnoid hemorrhage (SAH). The aim of this study was to establish a protocol for the management of vasospasm and demonstrate our experience of angioplasty using the Scepter XC balloon c...

Full description

Saved in:
Bibliographic Details
Published inBMC neurology Vol. 20; no. 1; pp. 1 - 8
Main Authors Chen, Chun-Ting, Chen, Ching-Chang, Wang, Alvin Yi-Chou, Wu, Yi-Ming, Chin, Shy-Chyi, Hsieh, Po-Chuan, Yeap, Mun-Chun, Hsu, Shih-Yuan, Lin, Ya-Jui
Format Journal Article
LanguageEnglish
Published London BioMed Central 07.07.2020
BioMed Central Ltd
BMC
Subjects
Online AccessGet full text
ISSN1471-2377
1471-2377
DOI10.1186/s12883-020-01856-4

Cover

Abstract Background Cerebral vasospasm still results in high morbidity and mortality rates in patients after aneurysmal subarachnoid hemorrhage (SAH). The aim of this study was to establish a protocol for the management of vasospasm and demonstrate our experience of angioplasty using the Scepter XC balloon catheter. Methods In this retrospective study, a computed tomography angiography and perfusion image was arranged if early symptoms occurred or on the 7th day following aneurysmal SAH. In patients with clear consciousness, balloon angioplasties were performed for symptomatic vasospasms, which were not improved within 6–12 h after maximal medical treatments. In unconscious patients, balloon angioplasties were performed for all patients with angiographic vasospasms. Results Fifty patients underwent Scepter XC balloon angioplasty among 396 consecutive patients who accepted endovascular or surgical treatments for ruptured aneurysms. All angioplasty procedures were successful without complications. 100% angiographic improvement and 94% clinical improvement were reached immediately after the angioplasties. A favorable functional outcome (modified Rankin Score of ≤2) could be achieved in 82% of patients. Even in patients with poor clinical grading (Hunt–Hess grade 4–5), a clinical improvement rate of 87.5% and favorable outcome rate was 70.8% could be achieved. Conclusion Balloon angioplasty with Scepter XC balloon catheter is safe and effective for post-SAH vasospasm. This device’s extra-compliant characteristics could considerably improve the quality of angioplasty procedures. For all patients, even those with poor neurological status, early treatment with combined protocol of nimodipine and angioplasty can have good clinical outcomes.
AbstractList Cerebral vasospasm still results in high morbidity and mortality rates in patients after aneurysmal subarachnoid hemorrhage (SAH). The aim of this study was to establish a protocol for the management of vasospasm and demonstrate our experience of angioplasty using the Scepter XC balloon catheter. In this retrospective study, a computed tomography angiography and perfusion image was arranged if early symptoms occurred or on the 7th day following aneurysmal SAH. In patients with clear consciousness, balloon angioplasties were performed for symptomatic vasospasms, which were not improved within 6-12 h after maximal medical treatments. In unconscious patients, balloon angioplasties were performed for all patients with angiographic vasospasms. Fifty patients underwent Scepter XC balloon angioplasty among 396 consecutive patients who accepted endovascular or surgical treatments for ruptured aneurysms. All angioplasty procedures were successful without complications. 100% angiographic improvement and 94% clinical improvement were reached immediately after the angioplasties. A favorable functional outcome (modified Rankin Score of [less than or equai to]2) could be achieved in 82% of patients. Even in patients with poor clinical grading (Hunt-Hess grade 4-5), a clinical improvement rate of 87.5% and favorable outcome rate was 70.8% could be achieved. Balloon angioplasty with Scepter XC balloon catheter is safe and effective for post-SAH vasospasm. This device's extra-compliant characteristics could considerably improve the quality of angioplasty procedures. For all patients, even those with poor neurological status, early treatment with combined protocol of nimodipine and angioplasty can have good clinical outcomes.
Background Cerebral vasospasm still results in high morbidity and mortality rates in patients after aneurysmal subarachnoid hemorrhage (SAH). The aim of this study was to establish a protocol for the management of vasospasm and demonstrate our experience of angioplasty using the Scepter XC balloon catheter. Methods In this retrospective study, a computed tomography angiography and perfusion image was arranged if early symptoms occurred or on the 7th day following aneurysmal SAH. In patients with clear consciousness, balloon angioplasties were performed for symptomatic vasospasms, which were not improved within 6–12 h after maximal medical treatments. In unconscious patients, balloon angioplasties were performed for all patients with angiographic vasospasms. Results Fifty patients underwent Scepter XC balloon angioplasty among 396 consecutive patients who accepted endovascular or surgical treatments for ruptured aneurysms. All angioplasty procedures were successful without complications. 100% angiographic improvement and 94% clinical improvement were reached immediately after the angioplasties. A favorable functional outcome (modified Rankin Score of ≤2) could be achieved in 82% of patients. Even in patients with poor clinical grading (Hunt–Hess grade 4–5), a clinical improvement rate of 87.5% and favorable outcome rate was 70.8% could be achieved. Conclusion Balloon angioplasty with Scepter XC balloon catheter is safe and effective for post-SAH vasospasm. This device’s extra-compliant characteristics could considerably improve the quality of angioplasty procedures. For all patients, even those with poor neurological status, early treatment with combined protocol of nimodipine and angioplasty can have good clinical outcomes.
Background Cerebral vasospasm still results in high morbidity and mortality rates in patients after aneurysmal subarachnoid hemorrhage (SAH). The aim of this study was to establish a protocol for the management of vasospasm and demonstrate our experience of angioplasty using the Scepter XC balloon catheter. Methods In this retrospective study, a computed tomography angiography and perfusion image was arranged if early symptoms occurred or on the 7th day following aneurysmal SAH. In patients with clear consciousness, balloon angioplasties were performed for symptomatic vasospasms, which were not improved within 6–12 h after maximal medical treatments. In unconscious patients, balloon angioplasties were performed for all patients with angiographic vasospasms. Results Fifty patients underwent Scepter XC balloon angioplasty among 396 consecutive patients who accepted endovascular or surgical treatments for ruptured aneurysms. All angioplasty procedures were successful without complications. 100% angiographic improvement and 94% clinical improvement were reached immediately after the angioplasties. A favorable functional outcome (modified Rankin Score of ≤2) could be achieved in 82% of patients. Even in patients with poor clinical grading (Hunt–Hess grade 4–5), a clinical improvement rate of 87.5% and favorable outcome rate was 70.8% could be achieved. Conclusion Balloon angioplasty with Scepter XC balloon catheter is safe and effective for post-SAH vasospasm. This device’s extra-compliant characteristics could considerably improve the quality of angioplasty procedures. For all patients, even those with poor neurological status, early treatment with combined protocol of nimodipine and angioplasty can have good clinical outcomes.
Cerebral vasospasm still results in high morbidity and mortality rates in patients after aneurysmal subarachnoid hemorrhage (SAH). The aim of this study was to establish a protocol for the management of vasospasm and demonstrate our experience of angioplasty using the Scepter XC balloon catheter.BACKGROUNDCerebral vasospasm still results in high morbidity and mortality rates in patients after aneurysmal subarachnoid hemorrhage (SAH). The aim of this study was to establish a protocol for the management of vasospasm and demonstrate our experience of angioplasty using the Scepter XC balloon catheter.In this retrospective study, a computed tomography angiography and perfusion image was arranged if early symptoms occurred or on the 7th day following aneurysmal SAH. In patients with clear consciousness, balloon angioplasties were performed for symptomatic vasospasms, which were not improved within 6-12 h after maximal medical treatments. In unconscious patients, balloon angioplasties were performed for all patients with angiographic vasospasms.METHODSIn this retrospective study, a computed tomography angiography and perfusion image was arranged if early symptoms occurred or on the 7th day following aneurysmal SAH. In patients with clear consciousness, balloon angioplasties were performed for symptomatic vasospasms, which were not improved within 6-12 h after maximal medical treatments. In unconscious patients, balloon angioplasties were performed for all patients with angiographic vasospasms.Fifty patients underwent Scepter XC balloon angioplasty among 396 consecutive patients who accepted endovascular or surgical treatments for ruptured aneurysms. All angioplasty procedures were successful without complications. 100% angiographic improvement and 94% clinical improvement were reached immediately after the angioplasties. A favorable functional outcome (modified Rankin Score of ≤2) could be achieved in 82% of patients. Even in patients with poor clinical grading (Hunt-Hess grade 4-5), a clinical improvement rate of 87.5% and favorable outcome rate was 70.8% could be achieved.RESULTSFifty patients underwent Scepter XC balloon angioplasty among 396 consecutive patients who accepted endovascular or surgical treatments for ruptured aneurysms. All angioplasty procedures were successful without complications. 100% angiographic improvement and 94% clinical improvement were reached immediately after the angioplasties. A favorable functional outcome (modified Rankin Score of ≤2) could be achieved in 82% of patients. Even in patients with poor clinical grading (Hunt-Hess grade 4-5), a clinical improvement rate of 87.5% and favorable outcome rate was 70.8% could be achieved.Balloon angioplasty with Scepter XC balloon catheter is safe and effective for post-SAH vasospasm. This device's extra-compliant characteristics could considerably improve the quality of angioplasty procedures. For all patients, even those with poor neurological status, early treatment with combined protocol of nimodipine and angioplasty can have good clinical outcomes.CONCLUSIONBalloon angioplasty with Scepter XC balloon catheter is safe and effective for post-SAH vasospasm. This device's extra-compliant characteristics could considerably improve the quality of angioplasty procedures. For all patients, even those with poor neurological status, early treatment with combined protocol of nimodipine and angioplasty can have good clinical outcomes.
Background Cerebral vasospasm still results in high morbidity and mortality rates in patients after aneurysmal subarachnoid hemorrhage (SAH). The aim of this study was to establish a protocol for the management of vasospasm and demonstrate our experience of angioplasty using the Scepter XC balloon catheter. Methods In this retrospective study, a computed tomography angiography and perfusion image was arranged if early symptoms occurred or on the 7th day following aneurysmal SAH. In patients with clear consciousness, balloon angioplasties were performed for symptomatic vasospasms, which were not improved within 6-12 h after maximal medical treatments. In unconscious patients, balloon angioplasties were performed for all patients with angiographic vasospasms. Results Fifty patients underwent Scepter XC balloon angioplasty among 396 consecutive patients who accepted endovascular or surgical treatments for ruptured aneurysms. All angioplasty procedures were successful without complications. 100% angiographic improvement and 94% clinical improvement were reached immediately after the angioplasties. A favorable functional outcome (modified Rankin Score of [less than or equai to]2) could be achieved in 82% of patients. Even in patients with poor clinical grading (Hunt-Hess grade 4-5), a clinical improvement rate of 87.5% and favorable outcome rate was 70.8% could be achieved. Conclusion Balloon angioplasty with Scepter XC balloon catheter is safe and effective for post-SAH vasospasm. This device's extra-compliant characteristics could considerably improve the quality of angioplasty procedures. For all patients, even those with poor neurological status, early treatment with combined protocol of nimodipine and angioplasty can have good clinical outcomes. Keywords: Balloon angioplasty; subarachnoid hemorrhage, Cerebral aneurysm, Aneurysm rupture, Scepter XC balloon
Abstract Background Cerebral vasospasm still results in high morbidity and mortality rates in patients after aneurysmal subarachnoid hemorrhage (SAH). The aim of this study was to establish a protocol for the management of vasospasm and demonstrate our experience of angioplasty using the Scepter XC balloon catheter. Methods In this retrospective study, a computed tomography angiography and perfusion image was arranged if early symptoms occurred or on the 7th day following aneurysmal SAH. In patients with clear consciousness, balloon angioplasties were performed for symptomatic vasospasms, which were not improved within 6–12 h after maximal medical treatments. In unconscious patients, balloon angioplasties were performed for all patients with angiographic vasospasms. Results Fifty patients underwent Scepter XC balloon angioplasty among 396 consecutive patients who accepted endovascular or surgical treatments for ruptured aneurysms. All angioplasty procedures were successful without complications. 100% angiographic improvement and 94% clinical improvement were reached immediately after the angioplasties. A favorable functional outcome (modified Rankin Score of ≤2) could be achieved in 82% of patients. Even in patients with poor clinical grading (Hunt–Hess grade 4–5), a clinical improvement rate of 87.5% and favorable outcome rate was 70.8% could be achieved. Conclusion Balloon angioplasty with Scepter XC balloon catheter is safe and effective for post-SAH vasospasm. This device’s extra-compliant characteristics could considerably improve the quality of angioplasty procedures. For all patients, even those with poor neurological status, early treatment with combined protocol of nimodipine and angioplasty can have good clinical outcomes.
ArticleNumber 271
Audience Academic
Author Chen, Chun-Ting
Wu, Yi-Ming
Hsieh, Po-Chuan
Hsu, Shih-Yuan
Wang, Alvin Yi-Chou
Chen, Ching-Chang
Lin, Ya-Jui
Yeap, Mun-Chun
Chin, Shy-Chyi
Author_xml – sequence: 1
  givenname: Chun-Ting
  surname: Chen
  fullname: Chen, Chun-Ting
  organization: Department of Neurosurgery, Stroke Center & Neurointervention, Chang Gung Memorial Hospital, Chang Gung Medical Center and University
– sequence: 2
  givenname: Ching-Chang
  orcidid: 0000-0001-6816-3963
  surname: Chen
  fullname: Chen, Ching-Chang
  email: jcchen130@gmail.com, 8702047@cgmh.org.tw
  organization: Department of Neurosurgery, Stroke Center & Neurointervention, Chang Gung Memorial Hospital, Chang Gung Medical Center and University
– sequence: 3
  givenname: Alvin Yi-Chou
  surname: Wang
  fullname: Wang, Alvin Yi-Chou
  organization: Department of Neurosurgery, Guangdong Provincial Hospital of Chinese Medicine
– sequence: 4
  givenname: Yi-Ming
  surname: Wu
  fullname: Wu, Yi-Ming
  organization: Department of Radiology, Division of Neuroradiology, Linkou Chang Gung Memorial Hospital & Chang Gung University
– sequence: 5
  givenname: Shy-Chyi
  surname: Chin
  fullname: Chin, Shy-Chyi
  organization: Department of Radiology, Division of Neuroradiology, Linkou Chang Gung Memorial Hospital & Chang Gung University
– sequence: 6
  givenname: Po-Chuan
  surname: Hsieh
  fullname: Hsieh, Po-Chuan
  organization: Department of Neurosurgery, Stroke Center & Neurointervention, Chang Gung Memorial Hospital, Chang Gung Medical Center and University
– sequence: 7
  givenname: Mun-Chun
  surname: Yeap
  fullname: Yeap, Mun-Chun
  organization: Department of Neurosurgery, Stroke Center & Neurointervention, Chang Gung Memorial Hospital, Chang Gung Medical Center and University
– sequence: 8
  givenname: Shih-Yuan
  surname: Hsu
  fullname: Hsu, Shih-Yuan
  organization: Department of Neurosurgery, Kaohsiung Chang Gung Memorial Hospital
– sequence: 9
  givenname: Ya-Jui
  surname: Lin
  fullname: Lin, Ya-Jui
  organization: Department of Neurosurgery, Stroke Center & Neurointervention, Chang Gung Memorial Hospital, Chang Gung Medical Center and University
BookMark eNp9kktv1DAUhSNURB_wB1hFYsMmrd92NkjVqEClCjYgsbMcxwkeJXawk6JZ8de501QtU6EqCz9yznd1r89pcRRicEXxFqNzjJW4yJgoRStEUIWw4qJiL4oTzCSuCJXy6J_9cXGa8xYhLBXDr4pjSgTlqiYnxZ8rk4ZdmedkZtfvytiV2bppdqn8sSkbMwwxhtKE3sdpMHnewb4tsx-XYTbBxSWXX_wYWz_54EofuiV7MHQxlbcmxzyZPMIJML996Mu0TPOSXAsUt6RdHl8XLzszZPfmfj0rvn-8-rb5XN18_XS9ubypLFdsrljHnGw6SbisLa0Fb3AniBTGtjUSkjGCOowlUkwoyQRyiDusCBwMrmld07PieuW20Wz1lPxo0k5H4_XdRUy9Nmn2dnC6bYzgjrGWN4hJi2tBDMBMVxuOGLXA-rCypqUZXWtdgOkNB9DDP8H_1H281ZLSmlMMgPf3gBR_LS7PevQw9WFYJ6oJI5gJLjgF6bsn0m1cUoBR7VVMwrMr8ajqDTQArxChrt1D9aWAkNQQgj3r_D8q-Fo3egvZ6jzcHxjIarAp5pxc99AjRnofQb1GUEME9V0ENQOTemKyfjYzpAKq-eF5K12tGeqE3qXHZp9x_QVEZ_E4
CitedBy_id crossref_primary_10_3390_jcm11164642
crossref_primary_10_1007_s00701_021_04935_8
crossref_primary_10_1186_s12883_022_02862_4
crossref_primary_10_1136_jnis_2023_020544
crossref_primary_10_1177_15910199211060987
crossref_primary_10_20935_AcadBiol6157
crossref_primary_10_5334_jbsr_3714
crossref_primary_10_1007_s00062_024_01390_7
crossref_primary_10_1088_1361_6498_ac32a2
crossref_primary_10_3390_bioengineering10070797
Cites_doi 10.3171/jns.1991.74.6.0985
10.1161/01.str.30.7.1402
10.1159/000477467
10.1136/neurintsurg-2014-011285
10.3171/jns.2004.101.1.0154
10.3171/jns.1990.73.1.0037
10.1016/j.wneu.2018.05.005
10.1161/STR.0b013e3182587839
10.1016/j.clineuro.2013.12.012
10.1136/jnis.2009.000919
10.1136/neurintsurg-2012-010572
10.1016/j.wneu.2011.02.030
10.3348/kjr.2015.16.1.180
10.3174/ajnr.A0747
10.1161/01.str.26.11.2061
10.3174/ajnr.A6124
10.3174/ajnr.A2246
10.1093/ons/opy202
10.1007/s00234-010-0752-z
10.1227/00006123-198209000-00001
10.1136/neurintsurg-2013-011043
10.1177/1591019917699980
10.1097/00006123-199905000-00022
ContentType Journal Article
Copyright The Author(s) 2020
COPYRIGHT 2020 BioMed Central Ltd.
2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author(s) 2020
– notice: COPYRIGHT 2020 BioMed Central Ltd.
– notice: 2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID C6C
AAYXX
CITATION
3V.
7TK
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1186/s12883-020-01856-4
DatabaseName Springer Nature OA Free Journals
CrossRef
ProQuest Central (Corporate)
Neurosciences Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
Publicly Available Content Database

MEDLINE - Academic


Database_xml – sequence: 1
  dbid: C6C
  name: Springer Nature OA Free Journals
  url: http://www.springeropen.com/
  sourceTypes: Publisher
– sequence: 2
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: http://www.proquest.com/pqcentral?accountid=15518
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1471-2377
EndPage 8
ExternalDocumentID oai_doaj_org_article_dba65e44d5b047c1962ae18af9a5043c
PMC7339531
A628892373
10_1186_s12883_020_01856_4
GeographicLocations United States--US
California
GeographicLocations_xml – name: United States--US
– name: California
GrantInformation_xml – fundername: Chang Gung Memorial Hospital, Linkou
  grantid: CMRPG3K0071
  funderid: http://dx.doi.org/10.13039/501100005795
– fundername: ;
  grantid: CMRPG3K0071
GroupedDBID ---
0R~
23N
2WC
53G
5VS
6J9
6PF
7X7
88E
8FI
8FJ
AAFWJ
AAJSJ
AASML
AAWTL
ABDBF
ABIVO
ABUWG
ACGFO
ACGFS
ACIHN
ACPRK
ACUHS
ADBBV
ADRAZ
ADUKV
AEAQA
AENEX
AFKRA
AFPKN
AHBYD
AHMBA
AHYZX
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BENPR
BFQNJ
BMC
BPHCQ
BVXVI
C6C
CCPQU
CS3
DIK
DU5
E3Z
EAD
EAP
EAS
EBD
EBLON
EBS
EMB
EMK
EMOBN
ESX
F5P
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IGS
IHR
INH
INR
ITC
KQ8
M1P
M48
M~E
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PJZUB
PPXIY
PQQKQ
PROAC
PSQYO
PUEGO
RBZ
RNS
ROL
RPM
RSV
SMD
SOJ
SV3
TR2
TUS
UKHRP
W2D
WOQ
WOW
XSB
AAYXX
ALIPV
CITATION
3V.
7TK
7XB
8FK
AZQEC
DWQXO
K9.
PKEHL
PQEST
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c584t-4f4e7bf72579c3965b1f6276acd90674420f117084687460e05e182687a193993
IEDL.DBID C6C
ISSN 1471-2377
IngestDate Wed Aug 27 01:21:58 EDT 2025
Thu Aug 21 17:57:07 EDT 2025
Thu Sep 04 22:01:12 EDT 2025
Fri Jul 25 06:14:09 EDT 2025
Tue Jun 17 21:28:36 EDT 2025
Tue Sep 16 09:47:14 EDT 2025
Tue Jul 01 00:37:32 EDT 2025
Thu Apr 24 22:59:01 EDT 2025
Sat Sep 06 07:35:57 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Cerebral aneurysm
Scepter XC balloon
Aneurysm rupture
Balloon angioplasty; subarachnoid hemorrhage
Language English
License Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c584t-4f4e7bf72579c3965b1f6276acd90674420f117084687460e05e182687a193993
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0001-6816-3963
OpenAccessLink https://doi.org/10.1186/s12883-020-01856-4
PMID 32635892
PQID 2424785686
PQPubID 44772
PageCount 8
ParticipantIDs doaj_primary_oai_doaj_org_article_dba65e44d5b047c1962ae18af9a5043c
pubmedcentral_primary_oai_pubmedcentral_nih_gov_7339531
proquest_miscellaneous_2421465653
proquest_journals_2424785686
gale_infotracmisc_A628892373
gale_infotracacademiconefile_A628892373
crossref_primary_10_1186_s12883_020_01856_4
crossref_citationtrail_10_1186_s12883_020_01856_4
springer_journals_10_1186_s12883_020_01856_4
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2020-07-07
PublicationDateYYYYMMDD 2020-07-07
PublicationDate_xml – month: 07
  year: 2020
  text: 2020-07-07
  day: 07
PublicationDecade 2020
PublicationPlace London
PublicationPlace_xml – name: London
PublicationTitle BMC neurology
PublicationTitleAbbrev BMC Neurol
PublicationYear 2020
Publisher BioMed Central
BioMed Central Ltd
BMC
Publisher_xml – name: BioMed Central
– name: BioMed Central Ltd
– name: BMC
References ME Linskey (1856_CR10) 1991; 74
JJ Heit (1856_CR13) 2015; 7
ED Greenberg (1856_CR21) 2010; 31
AM Spiotta (1856_CR15) 2015; 7
NF Kassell (1856_CR5) 1982; 11
JL Brisman (1856_CR11) 2004; 101
NF Kassell (1856_CR3) 1990; 73
BA Gross (1856_CR17) 2017; 6
S John (1856_CR14) 2014; 6
G Seidel (1856_CR19) 1995; 26
D Cooke (1856_CR1) 2010; 2
C Charpentier (1856_CR22) 1999; 30
ES Connolly Jr (1856_CR2) 2012; 43
CM Lin (1856_CR16) 2019; 16
MA Labeyrie (1856_CR23) 2019; 40
RH Rosenwasser (1856_CR6) 1999; 44
N Badjatia (1856_CR4) 2004; 25
NS Chaudhry (1856_CR24) 2017; 23
PC Sanelli (1856_CR20) 2011; 53
N Chalouhi (1856_CR8) 2014; 118
CC Chen (1856_CR9) 2018; 116
GJ Velat (1856_CR7) 2011; 76
Y Murayama (1856_CR25) 2003; 24
YD Cho (1856_CR12) 2015; 16
AM Laslo (1856_CR18) 2008; 29
References_xml – volume: 74
  start-page: 985
  issue: 6
  year: 1991
  ident: 1856_CR10
  publication-title: Case report J Neurosurg
  doi: 10.3171/jns.1991.74.6.0985
– volume: 30
  start-page: 1402
  issue: 7
  year: 1999
  ident: 1856_CR22
  publication-title: Stroke.
  doi: 10.1161/01.str.30.7.1402
– volume: 25
  start-page: 819
  issue: 5
  year: 2004
  ident: 1856_CR4
  publication-title: AJNR Am J Neuroradiol
– volume: 6
  start-page: 229
  issue: 3–4
  year: 2017
  ident: 1856_CR17
  publication-title: Interv Neurol
  doi: 10.1159/000477467
– volume: 7
  start-page: 721
  issue: 10
  year: 2015
  ident: 1856_CR15
  publication-title: J Neurointerv Surg.
  doi: 10.1136/neurintsurg-2014-011285
– volume: 101
  start-page: 154
  issue: 1
  year: 2004
  ident: 1856_CR11
  publication-title: J Neurosurg
  doi: 10.3171/jns.2004.101.1.0154
– volume: 73
  start-page: 37
  issue: 1
  year: 1990
  ident: 1856_CR3
  publication-title: J Neurosurg
  doi: 10.3171/jns.1990.73.1.0037
– volume: 116
  start-page: e452
  year: 2018
  ident: 1856_CR9
  publication-title: World Neurosurg
  doi: 10.1016/j.wneu.2018.05.005
– volume: 43
  start-page: 1711
  issue: 6
  year: 2012
  ident: 1856_CR2
  publication-title: Stroke.
  doi: 10.1161/STR.0b013e3182587839
– volume: 118
  start-page: 26
  year: 2014
  ident: 1856_CR8
  publication-title: Clin Neurol Neurosurg
  doi: 10.1016/j.clineuro.2013.12.012
– volume: 2
  start-page: 139
  issue: 2
  year: 2010
  ident: 1856_CR1
  publication-title: J Neurointerv Surg
  doi: 10.1136/jnis.2009.000919
– volume: 6
  start-page: 125
  issue: 2
  year: 2014
  ident: 1856_CR14
  publication-title: J Neurointerv Surg.
  doi: 10.1136/neurintsurg-2012-010572
– volume: 76
  start-page: 446
  issue: 5
  year: 2011
  ident: 1856_CR7
  publication-title: World Neurosurg
  doi: 10.1016/j.wneu.2011.02.030
– volume: 16
  start-page: 180
  issue: 1
  year: 2015
  ident: 1856_CR12
  publication-title: Korean J Radiol
  doi: 10.3348/kjr.2015.16.1.180
– volume: 29
  start-page: 79
  issue: 1
  year: 2008
  ident: 1856_CR18
  publication-title: AJNR Am J Neuroradiol
  doi: 10.3174/ajnr.A0747
– volume: 26
  start-page: 2061
  issue: 11
  year: 1995
  ident: 1856_CR19
  publication-title: Stroke.
  doi: 10.1161/01.str.26.11.2061
– volume: 40
  start-page: 1342
  issue: 8
  year: 2019
  ident: 1856_CR23
  publication-title: AJNR Am J Neuroradiol
  doi: 10.3174/ajnr.A6124
– volume: 24
  start-page: 133
  issue: 1
  year: 2003
  ident: 1856_CR25
  publication-title: AJNR Am J Neuroradiol
– volume: 31
  start-page: 1853
  issue: 10
  year: 2010
  ident: 1856_CR21
  publication-title: AJNR Am J Neuroradiol
  doi: 10.3174/ajnr.A2246
– volume: 16
  start-page: 692
  issue: 6
  year: 2019
  ident: 1856_CR16
  publication-title: Oper Neurosurg (Hagerstown)
  doi: 10.1093/ons/opy202
– volume: 53
  start-page: 425
  issue: 6
  year: 2011
  ident: 1856_CR20
  publication-title: Neuroradiology.
  doi: 10.1007/s00234-010-0752-z
– volume: 11
  start-page: 337
  issue: 3
  year: 1982
  ident: 1856_CR5
  publication-title: Neurosurgery.
  doi: 10.1227/00006123-198209000-00001
– volume: 7
  start-page: 56
  issue: 1
  year: 2015
  ident: 1856_CR13
  publication-title: J Neurointerv Surg
  doi: 10.1136/neurintsurg-2013-011043
– volume: 23
  start-page: 372
  issue: 4
  year: 2017
  ident: 1856_CR24
  publication-title: Interv Neuroradiol
  doi: 10.1177/1591019917699980
– volume: 44
  start-page: 975
  issue: 5
  year: 1999
  ident: 1856_CR6
  publication-title: Neurosurgery.
  doi: 10.1097/00006123-199905000-00022
SSID ssj0017841
Score 2.3158884
Snippet Background Cerebral vasospasm still results in high morbidity and mortality rates in patients after aneurysmal subarachnoid hemorrhage (SAH). The aim of this...
Background Cerebral vasospasm still results in high morbidity and mortality rates in patients after aneurysmal subarachnoid hemorrhage (SAH). The aim of this...
Cerebral vasospasm still results in high morbidity and mortality rates in patients after aneurysmal subarachnoid hemorrhage (SAH). The aim of this study was to...
Abstract Background Cerebral vasospasm still results in high morbidity and mortality rates in patients after aneurysmal subarachnoid hemorrhage (SAH). The aim...
SourceID doaj
pubmedcentral
proquest
gale
crossref
springer
SourceType Open Website
Open Access Repository
Aggregation Database
Enrichment Source
Index Database
Publisher
StartPage 1
SubjectTerms Aneurysm
Aneurysm rupture
Aneurysms
Angiography
Angioplasty
Balloon angioplasty
Balloon angioplasty; subarachnoid hemorrhage
Balloon catheters
Balloon treatment
Blood pressure
Cardiac patients
Cardiovascular system
Care and treatment
CAT scans
Catheters
Cerebral aneurysm
Cerebrovascular disease and stroke
Computed tomography
Consciousness
Embolization
Health aspects
Medical imaging
Medical treatment
Medicine
Medicine & Public Health
Morbidity
Mortality
Neurochemistry
Neurology
Neurosurgery
Nimodipine
Patients
Perfusion
Research Article
Scepter XC balloon
Stents
Stroke
Subarachnoid hemorrhage
Therapeutics
Thromboembolism
Vasoconstriction
Veins & arteries
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQD4gLojxEoCAjIXGAqHHi2MmxVK0qpPZEpb1ZfsJKNFmtd6l64q8z4yRLQwVcuGVjxzvxjO1vMvY3hLytSlMGW_Hctk6Ag9KYvPWW5Y1j1lkmDC_xvPP5hTi75J8W9eJWqi_cEzbQAw8dd-iMFrXn3NWm4NKCwZTas0aHViP5lsXZt2iLyZka4wcYTZuOyDTiMDJMqpujq1TAAgVCzZahxNZ_d06-u0_yt2BpWoNOH5GHI3ikR4PQ--Se7x6T--djePwJ-ZHoimkcGGdvaB9oxG0rfk0Xx9RgjL3vqO6-LPsVoObNDVw7Gpe4q1B3vt9GegG6c5jP2lOwvS1-S6OAa-l3HXuYfOIV_IJmrkE-ut6uMP7goBUPqolXT8nl6cnn47N8zLCQWwAem5wH7qUJEsZta6tW1IYFUUqhrWthGeO8LAKmpgGQ0kguCl_UHh2SRmoAfgBtnpG9ru_8c0JrzQJnFjTMAZRwZrw2RWVqgA_gE4UyI2zqcGVH-nHMgvFNJTekEWpQkgIlqaQkxTPyfvfMaiDf-Gvtj6jHXU0kzk43wJzUaE7qX-aUkXdoBQqHN4hn9XhKAV4SibLUEaZnBlAsq4wczGrCsLTz4smO1DgtRIVncSQI24iMvNkV45O41S3pGeswJLGroQk5s7_Zm81LuuXXRA0uq6qFWTUjHyZL_fXnf-65F_-j516SB2UaYPjp-4DsbdZb_woA28a8TmPzJ4x8PQ0
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagSIgL4ikCLTISEgeIGieOnZxQW1FVSO2JSnuz_EpZiSbLehfUU_96Z7zOVqGit92147UzD894xt8Q8rEqTdnZiue2dQIclMbkrbcsbxyzzjJheIn3nU_PxMk5_z6rZ-nALaS0ylEnRkXtBotn5Pt4jUE2tWjE18XvHKtGYXQ1ldB4SB5F6DLgZznbOlwMY2rjRZlG7AeGpXVzdJgK2KZgapPNKGL239XMd7Ml_wmZxp3o-Bl5mkxIerCh-XPywPcvyOPTFCR_Sa4jaDENG9zZKzp0NGDyil_S2RE1GGkfeqr7i_mwANt5dQWfHQ1zzC3UvR_WgZ4BBR1WtfYUOHCNJ2oUrFv6R4cBVFC4hG8wzF-YH12uFxiFcDCKBwKFy1fk_Pjbj6OTPNVZyC2YH6ucd9xL00mQ3tZWragN60Qphbauhc2M87LosEANmCqN5KLwRe3RLWmkBvMPDJzXZKcfev-G0FqzjjMLdOZgmnBmvDZFZWowIsAz6sqMsPGFK5tAyLEWxi8VnZFGqA2RFBBJRSIpnpHP22cWGwiOe3sfIh23PRE-O_4wLC9UkkbljBa159zVpuDSghYqNSxJd61GRDebkU_IBQqFHKZndbqrAItEuCx1gEWawTSWVUZ2Jz1BOO20eeQjlZRDULesnJEP22Z8EhPeIp2xD0MouxqGkBP-m6xs2tLPf0aAcFlVLejWjHwZOfX2z___5t7eP9d35EkZRQePtnfJzmq59ntgkK3M-yh1N-rpNDs
  priority: 102
  providerName: ProQuest
– databaseName: Scholars Portal Journals: Open Access
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3db9MwED-NISFeEJ8iMJCRkHiAQJw4dvKA0JiYJqTuiUp9s2zHGZW2pDQt0Cf-de7cpFPYQOKtqT9i--58v8vZdwAvs9SmtctE7MpKooFS2Lj0jsdFxV3luLQipfvOk1N5MhWfZ_lsD4Z0R_0CdteadpRParo8f_vz2-YDCvz7IPCFfNdxSpkbkyGUoPrBV96Am6iZJBljE3HpVSAf23Bx5tp2I-UUYvhf3amvnp78w4UaNNPxXbjTQ0p2uOWBe7Dnm_twa9I7zR_ArxDEmHXbOLQb1taso8MsfslmR8yS571tmGnO5u0CsfRqg78r1s3prKFpfLvu2ClStKIs157hGq3pCxtDtMu-m67FLam7wCfs5geOjy3XC_JKVNiLR4J1Fw9hevzpy9FJ3OddiB3CkVUsauGVrRVKc-myUuaW1zJV0riqROUmRJrUlLAGoUuhhEx8knsyUwplEA4i4HkE-03b-MfAcsNrwR3SXSBUEdx6Y5PM5ggq0FKq0wj4sODa9UHJKTfGuQ7GSSH1lkgaiaQDkbSI4PWuzWIbkuOftT8SHXc1KZx2-KNdnuleOnVljcy9EFVuE6Ec7kqpwSmZujQU4c1F8Iq4QBMb4vCc6e8u4CQpfJY-pKTNCJVVFsHBqCYKqxsXD3ykB17XdENH4WALGcGLXTG1pANwgc5Uh1Nouxy7UCP-G81sXNLMv4aA4SrLStxrI3gzcOrly_--ck_-r_pTuJ0GUaJP3wewv1qu_TMEbCv7PEjhb3abO5Y
  priority: 102
  providerName: Scholars Portal
Title Early strategy of scepter XC balloon angioplasty and simultaneous Nimodipine infusion for vasospasm following ruptured aneurysm
URI https://link.springer.com/article/10.1186/s12883-020-01856-4
https://www.proquest.com/docview/2424785686
https://www.proquest.com/docview/2421465653
https://pubmed.ncbi.nlm.nih.gov/PMC7339531
https://doaj.org/article/dba65e44d5b047c1962ae18af9a5043c
Volume 20
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3dixMxEB-8OxBfxE9cPUsEwQdd3Oxmk93Ha7njEFrk8KD4EpJsVgvebum2yj35rzuTbqvrqeDL0jYfTXY-8ptMMgPwMkttWrtMxK6sJBoohY1L73hcVNxVjksrUrrvPJ3J80vxbp7P-zA5dBfmV_89L-TbjlM63JiMnASXFuzuAI5ynkkSwomc7D0G5D_bXYr5Y7vBwhPi89_UwjdPRv7mHg2rztk9uNvDRXaype99uOWbB3B72jvEH8L3EKCYddsYs9esrVlHB1X8is0nzJJXvW2YaT4t2iXi5PU1fq5Yt6BzhKbxaPazGVKrogzWniG3bWj3jCGSZV9N16K66a7wG3bzDcfHVpsleRwq7MUjMbqrR3B5dvphch73ORVih1BjHYtaeGVrhZJauqyUueW1TJU0ripx4RIiTWpKRoOwpFBCJj7JPZkghTII9RDMPIbDpm38E2C54bXgDmkqEIYIbr2xSWZzBAxoBdVpBHz3wrXrA45T3osvOhgehdRbImkkkg5E0iKC1_s2y224jX_WHhMd9zUpVHb4ATlI95KnK2tk7oWocpsI5VDjpAanZOrSUPQ2F8Er4gJNAo3Dc6a_l4CTpNBY-oQSMiMMVlkEx4OaKIhuWLzjI90rgk7T7RuFgy1kBC_2xdSSDrcFOlMdTmHrcuxCDfhvMLNhSbP4HIKBqywrUY9G8GbHqT___O9v7un_VX8Gd9IgSrStfQyH69XGP0cwtrYjOFBzNYKj8ens_cUoyOQobGzgcyoKfF6MP_4AB7kyZA
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3Nb9MwFLemIQEXNL5EYICRQBwgWpw4dnJAaAymjq09bVJvxnacrRJLuqZl6on_iL-R99ykU5jYbbe2dlLb7_e-_Oz3CHmbxCYubcJDmxcCHJTMhLmzLMwKZgvLhOEx3ncejsTghH8fp-MN8qe7C4PHKjuZ6AV1UVvcI9_BawwyS0UmPk8vQqwahdHVroTGChaHbnkJLlvz6eAr0PddHO9_O94bhG1VgdCCsp2HvOROmlICVnOb5CI1rBSxFNoWOYhuzuOoxHIsoJgzyUXkotShEZ5JDcZOjsmXQOTf4QnYVsA_crx28BjG8LqLOZnYaRiW8g3RQYtALcJS9JSfrxFwXRNcP535T4jWa779LfKgNVnp7gpjD8mGqx6Ru8M2KP-Y_PZJkmmzynO7pHVJGzws42Z0vEcNRvbriurqdFJPwVafL-FzQZsJnmXUlasXDR0BYgqsou0oIH6BO3gUrGn6Szc1iLzmHL7Bay5hfHS2mGLUo4C3OABEc_6EnNwKBZ6Szaqu3DNCU81KzizgioMpxJlx2kSJScFoAU-sjAPCugVXtk16jrU3firv_GRCrYikgEjKE0nxgHxYPzNdpfy4sfcXpOO6J6br9j_Us1PVcr8qjBap47xITcSlBakXa5iSLnONGeRsQN4jChQKFRie1e3dCJgkpudSu1gUGkxxmQRku9cThIHtN3c4Uq0watQV6wTkzboZn8QDdp7O2Idh6rwUXiF7-OvNrN9STc58QnKZJDnI8oB87JB69ef_X7nnN4_1Nbk3OB4eqaOD0eELcj_2bITb6ttkcz5buJdgDM7NK8-BlPy4bZb_C_XTbXs
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELagSBUXxFMEChgJiQNEjRPHTo5lYVUeXXGg0t4sv1JWoslqkwX1xF9nxkkWQgGJWxI_Ymdm7JmM5xtCnmWpSSub8diWToCBUpi49JbFhWPWWSYMTzHe-WQhjk_5u2W-_CWKP5x2H12SfUwDojTV3eHaVb2IF-KwZZgkN0bTJ4ENB15ylVwDSyVBvp6J2c6PgF61MVTmj-0m21FA7b-8Nl8-L_mb0zTsRfOb5MagRNKjnuq3yBVf3yb7J4Ob_A75HmCLadsjz17QpqItHl_xG7qcUYO-9qamuj5bNWvQnrsLuHa0XeHpQl37ZtvSBdDQYV5rT4EHt_hPjYJ-S7_qtoFFqD2HO-jmG4yPbrZr9EM46MUDidrzu-R0_ubT7DgeMi3EFhSQLuYV99JUEuS3tFkpcsMqkUqhrSthO-M8TSpMUQPKSiG5SHySezRMCqlBAQQV5x7Zq5va3yc016zizAKlOSgnnBmvTZKZHNQIsI2qNCJs_ODKDjDkmA3jiwrmSCFUTyQFRFKBSIpH5MWuzboH4fhn7VdIx11NBNAOD5rNmRrkUTmjRe45d7lJuLSwDqUapqSrUiOmm43Ic-QChWIOw7N6iFaASSJgljrCNM2gHMssIgeTmiCedlo88pEalodWYUyOhMEWIiJPd8XYEo-8BTpjHYZgdjl0ISf8N5nZtKRefQ4Q4TLLSlhdI_Jy5NSfL__7l3vwf9WfkP2Pr-fqw9vF-4fkehqkCv97H5C9brP1j0Bb68zjIJA_AHftOEM
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Early+strategy+of+scepter+XC+balloon+angioplasty+and+simultaneous+Nimodipine+infusion+for+vasospasm+following+ruptured+aneurysm&rft.jtitle=BMC+neurology&rft.au=Chen%2C+Chun-Ting&rft.au=Chen%2C+Ching-Chang&rft.au=Wang%2C+Alvin+Yi-Chou&rft.au=Wu%2C+Yi-Ming&rft.date=2020-07-07&rft.pub=BioMed+Central&rft.eissn=1471-2377&rft.volume=20&rft.issue=1&rft_id=info:doi/10.1186%2Fs12883-020-01856-4&rft.externalDocID=10_1186_s12883_020_01856_4
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2377&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2377&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2377&client=summon